Citadel Advisors’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,799
| Closed | -$18K | – | 7239 |
|
|
2024
Q4 | $18K | Buy |
+15,799
| New | +$18K | ﹤0.01% | 5658 |
|
|
2024
Q3 | – | Sell |
-61,391
| Closed | -$50K | – | 6931 |
|
|
2024
Q2 | $50K | Sell |
61,391
-43,602
| -42% | -$35.5K | ﹤0.01% | 5178 |
|
|
2024
Q1 | $131K | Sell |
104,993
-3,461
| -3% | -$4.33K | ﹤0.01% | 4964 |
|
|
2023
Q4 | $96.4K | Buy |
108,454
+50,828
| +88% | +$45.2K | ﹤0.01% | 4885 |
|
|
2023
Q3 | $52.4K | Sell |
57,626
-9,217
| -14% | -$8.39K | ﹤0.01% | 5069 |
|
|
2023
Q2 | $63.2K | Sell |
66,843
-403
| -0.6% | -$381 | ﹤0.01% | 4918 |
|
|
2023
Q1 | $64.4K | Buy |
67,246
+42,252
| +169% | +$40.5K | ﹤0.01% | 5075 |
|
|
2022
Q4 | $22.5K | Buy |
+24,994
| New | +$22.5K | ﹤0.01% | 5532 |
|
|
2022
Q3 | – | Sell |
-27,468
| Closed | -$69K | – | 6867 |
|
|
2022
Q2 | $69K | Buy |
27,468
+9,456
| +52% | +$23.8K | ﹤0.01% | 5419 |
|
|
2022
Q1 | $53K | Sell |
18,012
-38,545
| -68% | -$113K | ﹤0.01% | 5885 |
|
|
2021
Q4 | $283K | Buy |
+56,557
| New | +$283K | ﹤0.01% | 5169 |
|
|
2021
Q2 | – | Sell |
-39,253
| Closed | -$650K | – | 7236 |
|
|
2021
Q1 | $650K | Buy |
+39,253
| New | +$650K | ﹤0.01% | 4340 |
|